导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.04% | 292/826 |
| 近一周 | -0.27% | 267/874 |
| 近一月 | -2.59% | 364/873 |
| 近一季 | -6.76% | 435/865 |
| 近半年 | -2.29% | 415/845 |
| 近一年 | 13.20% | 267/802 |
| 近两年 | 55.46% | 372/736 |
| 近三年 | 16.91% | 421/659 |
| 成立以来 | 31.67% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.45% 386/1070 |
22.86% 367/1101 |
- - |
- - |
| 2025 | 25.98% 567/1065 |
-3.38% 968/1014 |
2.42% 473/1038 |
20.15% 607/1050 |
5.96% 108/1065 |
| 2024 | -13.78% 834/1011 |
-11.51% 815/960 |
-5.73% 675/983 |
11.25% 524/991 |
-7.10% 785/1011 |
| 2023 | 5.91% 40/952 |
9.09% 140/880 |
7.02% 27/895 |
-8.51% 529/915 |
-0.84% 161/952 |
| 2022 | -6.81% 47/867 |
-15.34% 279/773 |
19.12% 29/806 |
-12.02% 394/845 |
5.02% 206/867 |
| 2021 | 10.19% 248/740 |
-4.78% 331/580 |
17.56% 195/659 |
-2.86% 285/704 |
1.34% 380/740 |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 创金合信ESG责任投资股票C VS. 东吴新产业精选股票A(580008) |